Bogotá D. C., August 13, 2018. The District Tissue Bank of the District Institute of Science, Biotechnology and Innovation in Health -IDCBIS-, linked to the District Health Secretariat, has 70,000 cm2 available to benefit the most vulnerable population that has suffered burns by flame, boiling liquid, acid and electricity.
The IDCBIS District Blood Bank offers the service of irradiation of blood components, which consists of a treatment that is done by gamma radiation to red blood cells, platelets, single platelet concentrates (CUPs) and plasma, in order to inactivate the T lymphocytes present in these blood components and prevent Graft Vs. Host Disease (GVHD) in the recipient.
Optimal applications for the use of gamma irradiation are:
-Bone marrow transplant patients
-Patients with Hodgkin's disease
-Neonatal transfusion
-Immunosuppressed patients.
-Oncology patients
The IDCBIS District Blood Bank is the only one with specialized equipment for the irradiation of blood components and tissues using gamma irradiation with Cesium-137 with an optimal distribution of the dose throughout the blood component, which ensures that T lymphocytes do not proliferate.
The blood component irradiation service is provided 24 hours a day, 365 days a year to public and private institutions in Colombia.
The IDCBIS immunohematology laboratory performs the processing of the tests established by current legislation for blood donor samples and apheresis in fully automated platforms favoring a simple, fast, reliable and safe set-up.
Immunohematology referral service to all public institutions in the District and private institutions:
-Resolution of erythrocyte compatibilization cases.
-Extended studies for the diagnosis of autoimmune hemolytic anemia
-Support studies for the diagnosis and prevention of hemolytic disease of the fetus and newborn.
Tests for the identification of irregular antibodies, including allogeneic adsorption techniques, differential adsorption, differential adsorption with enzyme-treated red blood cells, among others.
It also has specialized professionals with extensive experience in the area, with postgraduate degrees and teaching experience, which has positioned the service as a training center for immunohematology with a clinical approach for residents of hematology, pediatric and adult hemato-oncology programs of the National University of Colombia and the University Foundation of Health Sciences - FUCS.
His research activities include the implementation of erythrocyte genotyping techniques, registration of donors with rare phenotypes and study of blood group system frequencies.
The Immunohematology service is provided 24 hours a day, 365 days a year to public and private institutions in Colombia.
IDCBIS will be presenting the Abstract "Tissue Engineered Constructs Based on Mesenchymal Stromal Cells and Acellular Dermis induce the Release of Repair Factors for Cutaneous Lesions "at the 5th World Congress of the Tissue Engineering and Regenerative Medicine in Tokyo -Japan #Termis2018. This is a great recognition to the research work of Dr. Gustavo Salguero, Dr. Ingrid Silva and the entire team of the Advanced Therapies Unit.
The IDCBIS National Registry of Hematopoietic Progenitor Cells Donors project team conducted a referral at INCUCAI, the agency that promotes, regulates, coordinates and oversees organ, tissue and cell donation and transplantation activities in Argentina.
Its main application is in burned patients, the patient when attacked by acid or by any substance that generates burns, loses its major defense which is the skin and is exposed to infections.
The donation of amniotic membrane, which is the placenta itself and comes from pregnant mothers with prior informed consent. Amniotic membrane is usually a biosecure tissue that undergoes cremation,
our goal is to avoid it and take the amniotic membrane, which has many benefits, at the IDCBIS District Tissue Bank, we are optimizing it for patients with burns, ophthalmologic injuries, etc., and we are using it for the treatment of patients who are in need of treatment.
(corneal lesions) and we are about to publish its application for dentistry with different oral mucosal lesions, its uses are multiple.
By donating the membrane you help thousands of patients to improve their quality of life.
The District Health Secretariat and the Council of Bogota awarded the order 'Social Responsibility Donate Bogota', to natural and legal persons committed to the donation of human organs and tissues in the Capital District.
The District Tissue Bank IDCBIS was awarded second place in Category 2: Promotion of donation for transplant purposes.
Likewise, the District Health Secretariat and the Council of Bogota made a special recognition to the institutions: Corporación Banco de Ojos de Colombia (Cobancol), Fundación Cosme y Damián and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), for their contribution in the promotion and operational management of organ and tissue donation for transplantation purposes, in 2017.
For 9 years, this initiative has recognized and honored people who encourage and promote, through awareness-raising activities, the donation of organs and tissues for transplant and implant purposes, and who support transplant patients.
During the first quarter of 2018, the District Health Secretariat managed the donation of 81 organs, corresponding to cadaveric donors (57 kidneys, 18 livers and 6 hearts), with which an equal number of patients were transplanted. Likewise, 31 living donor transplants were performed (21 kidneys and 10 livers).
The District Health Secretariat also reported that so far this year it has received 7 organs (4 kidneys and 3 livers) for transplant from other regions of the country, for a total of 83 beneficiaries.
IDCBIS, passion for science and life.
We would like to share with the entire community the Manifesto Challenges 2030 for science, technology, education and the environment.
About the Manifesto: Convened by the Colombian Academy of Exact, Physical and Natural Sciences with the purpose of reflecting on the opportunities that we have as a country and thinking about now, but especially in the following decades; 31 academics with different expertise and backgrounds met in Paipa, Boyacá, during January 26, 27 and 28, 2018. The discussion focused on four main axes: science and technology, education, environment and royalties.
Dr. Bernardo Camacho, director of the IDCBIS had the honor of participating along with Professor José Félix Patiño and Professor Juan José Yunesen in the inaugural conference of the XVIII Congress of Basic Sciences and Clinical Specialties, organized by the Association of Former Medical Students of the National University, AEXMUN, which is being held at the facilities of the Centro Empresarial y Recreativo El Cubo Colsubsidio in the city of Bogota.
The director of IDCBIS presented the conference entitled: Capacity Building in BioMedical Research: Experiencia del Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud- IDCBIS. There, the audience was informed about the Centralized Model in research and provision of services in Blood, Tissue and Cell Banking.
The lectures and papers presented at this congress are part of the theme: "Personalized Medicine and Technological Advances". "Two very ambitious topics, if we take into account that one encompasses the field of healthcare that individualizes medical care based on the unique information that each individual possesses, and at the same time allows individualizing the path for its management."This was stated by Dr. Oswaldo Borráez, Director of the National University Medical Alumni Association, AEXMUN.
You can learn more about the event at:
A group of prestigious researchers from the University of Miami and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), of the Mayor's Office of Bogota, are working together on the treatment of type I diabetes in Colombia.
Camillo Ricordi, Director of the Diabetes Research Institute; Diego Correa, Assistant Professor at the Miller School of Medicine of the University of Miami; Bernardo Camacho, Director of IDCBIS and Luis Gonzalo Morales Sánchez, Secretary of Health, met in the country's capital to exchange knowledge and experiences on the treatment of the disease.
"These prestigious scientists will share with us successful techniques and technologies for the transplantation of pancreatic islets in Type I Diabetes; what we are looking for is that patients, especially children and adolescents are not dependent on insulin and have a better quality of life," explained Bernardo Camacho, director of the IDCBIS.
In the last decade, important clinical evidence has been generated that shows the safety and efficacy of this treatment based on cell therapy, especially from the experience of the Diabetes Research Institute (DRI) of the Miller School of Medicine of the University of Miami. This group, led by Dr. Camllo Ricordi, has been the world pioneer in pancreatic islet transplantation, with more than 25 years of experience in the application of this procedure.
Pancreatic Islet Transplantation can be improved ostensibly with the help of other therapies, on which the Cell Therapy Unit of IDCBIS is working.
District Institute of Science, Biotechnology and Innovation in Health IDCBIS 2023. All rights reserved
English 
Spanish